Lockheed Martin Investment Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,410
Closed -$79.3K 140
2024
Q2
$79.3K Sell
18,410
-11,228
-38% -$53.8K ﹤0.01% 147
2024
Q1
$220K Sell
29,638
-8,900
-23% -$34.1K 0.02% 147
2023
Q4
$291K Buy
38,538
+17,610
+84% +$86.2K 0.02% 143
2023
Q3
$248K Sell
20,928
-28,210
-57% -$226K 0.02% 137
2023
Q2
$455K Buy
49,138
+5,200
+12% +$44K 0.03% 132
2023
Q1
$361K Hold
43,938
0.02% 138
2022
Q4
$489K Buy
43,938
+4,700
+12% +$54.6K 0.03% 131
2022
Q3
$465K Sell
39,238
-6,500
-14% -$98.5K 0.04% 127
2022
Q2
$698K Sell
45,738
-16,090
-26% -$289K 0.05% 127
2022
Q1
$1.31M Sell
61,828
-6,400
-9% -$138K 0.07% 125
2021
Q4
$1.61M Buy
+68,228
New +$1.46M 0.09% 125

Other funds holding MPT

Lockheed Martin Investment Management's MPT Position: Q3 2024 in Review

Lockheed Martin Investment Management sold out of Medical Properties Trust (MPT) in Q3 2024, closing a stake of 18,410 shares — an estimated $79.3K sold.

Lockheed Martin Investment Management first reported a position in MPT in Q4 2021 and held it in 11 quarters. The position peaked at $1.61M in Q4 2021. 506 funds tracked by Wall St. Rank hold MPT as of Q3 2024.

  • Lockheed Martin Investment Management reported no remaining Medical Properties Trust position as of Q3 2024 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 18,410 Medical Properties Trust shares in Q3 2024, an estimated $79.3K.
  • Lockheed Martin Investment Management first reported a position in Medical Properties Trust in Q4 2021 and held it in 11 quarters.
  • Lockheed Martin Investment Management's Medical Properties Trust position peaked at $1.61M in Q4 2021.
  • 506 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2024.

Based on Lockheed Martin Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.